Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.820
-0.080 (-2.05%)
Apr 29, 2026, 2:56 PM EDT - Market open
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$389,326
Profits / Employee
-$615,756
Market Cap
223.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Adagene | 128 |
| Arcturus Therapeutics Holdings | 111 |
| Artiva Biotherapeutics | 104 |
| SAB Biotherapeutics | 86 |
| Camp4 Therapeutics | 48 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
OBIO News
- 6 days ago - Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 - GlobeNewsWire
- 6 weeks ago - Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 7 weeks ago - Orchestra BioMed Holdings Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Orchestra BioMed Holdings Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT - GlobeNewsWire
- 2 months ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 2 months ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire